QAV680, cetirizine and their combination reduce nasal symptoms in patients with intermittent allergic rhinitis in an environmental exposure chamber Source: International Congress 2014 – Allergy and asthma: novel findings based on human cell biology Year: 2014
Subcutaneous allergen specific immunotherapy and immunological response in patients with bronchial asthma and allergic rhinitis in India Source: International Congress 2014 – Intervening in allergic asthma Year: 2014
Efficacy and safety of 10 day treatment with the CRTh2 antagonist QAV680 evaluated in patients with allergic rhinitis in an environmental exposure chamber Source: International Congress 2014 – Allergy and asthma: novel findings based on human cell biology Year: 2014
Comparative efficacy of different groups of drugs for the treatment of bronchial asthma in combination with allergic rhinitis Source: International Congress 2014 – Intervening in allergic asthma Year: 2014
Distribution of mast cells and their interactions with nerve in allergic rhinitis Source: International Congress 2015 – Asthma and lung immunology Year: 2015
Expression of eotaxins in nasal mucosa of allergic patients after intranasal provocation- preliminary study Source: Annual Congress 2013 –Cell biology and murine models of asthma and inflammation Year: 2013
Therapeutic effectpredictors during sublingual immunotherapy for Japanese seasonal allergic rhinitis Source: International Congress 2014 – Intervening in allergic asthma Year: 2014
Magnitude of the late allergen response in seasonal vs perennial allergen bronchoprovocation Source: Annual Congress 2013 –Genetics and mechanisms of, and tests for, allergy Year: 2013
Serum IL-10 and IL-17 are not related to the efficacy of allergen specific immunotherapy in asthma Source: International Congress 2014 – Allergy and asthma: novel findings based on human cell biology Year: 2014
Influence of maternal bronchial asthma clinical phenotype on development of allergies in children Source: International Congress 2014 – Paediatric asthma: epidemiology and risk factors Year: 2014
Impairment of leptin/leptin receptor pathway in nasal epithelium from allergic turbinates Source: International Congress 2016 – What's new in biomarker analysis? Year: 2016
Fungal sensitization in patients with moderate and severe asthma Source: International Congress 2014 – Clinical allergy Year: 2014
LATE-BREAKING ABSTRACT: Effects of a dual CysLT1/2 antagonist, ONO-6950, on allergen-induced airway responses in subjects with mild allergic asthma. Source: International Congress 2014 – Latest insights in airway diseases Year: 2014
Effects of airborne pollen levels on drug consumption for seasonal allergic rhinoconjunctivitis: A ten-year French study Source: International Congress 2014 – Intervening in allergic asthma Year: 2014
Pim1 kinase affects allergic asthma in a HDM-driven mice model Source: International Congress 2014 – Mechanistic murine studies of asthma and lung inflammation Year: 2014
Ultra-rush sublingual immunotherapy: Safety of use for patients with various allergic manifestations Source: International Congress 2015 – Modulating the immune system in COPD and asthma Year: 2015
Usefulness of nasal provocation test in the diagnosis of mite allergic rhinitis: Standard or rapid? Source: Annual Congress 2013 –Genetics and mechanisms of, and tests for, allergy Year: 2013
Autoimmune disorders in allergen immunotherapy, allergic rhinitis, and non-allergic patients Source: International Congress 2014 – Intervening in allergic asthma Year: 2014
25-hydroxyvitamin D promotes the long-term effects of specific immunotherapy (SIT) in allergic airway inflammation in mice Source: International Congress 2014 – Animal models: asthma, COPD and beyond Year: 2014
Combined therapy of asthma and allergic rhinitis Source: Annual Congress 2013 –Treatment of asthma Year: 2013